𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer’s disease

✍ Scribed by Katy A. Chalmers; Gordon K. Wilcock; Harry V. Vinters; Elaine K. Perry; Robert Perry; Clive G. Ballard; Seth Love

Publisher
Springer
Year
2009
Tongue
English
Weight
164 KB
Volume
256
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hypertension, white matter change and re
Hypertension, white matter change and response to cholinesterase inhibitors in Alzheimer's disease
✍ Peter J. Connelly; Neil P. Prentice; Kenneth G. Fowler 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

Background Cholinesterase inhibitors are used to treat mild to moderate Alzheimer's disease. Their role in patients with concurrent cerebrovascular disease has been less well studied, and the influence of vascular risk factors on response to treatment is uncertain. We investigated the effect of hype